Trial Profile

A study of brain amyloid and tau deposition using Florbetapir and T807 in young onset Alzheimer's disease

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
Indications Alzheimer's disease
Focus Pharmacodynamics

Most Recent Events

11 Feb 2016 Planned End Date changed from 30 Nov 2015 to 30 Oct 2016 as reported by United Kingdom Clinical Research Network.
26 Nov 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com